IBC Life Sciences

The leading provider of scientific, technological and business information

Main menu

My IBC

Login form

Sign Up

Antibody Development & Production

CSS

Event Information

The Most Comprehensive, Single-Track Event Covering the Technical and Scientific Innovations in Upstream and Downstream Processing

March 03 - 05, 2010 · La Costa Resort & Spa · Carlsbad, CA

Document Title

Event Overview

Event Overview

Antibody Development & Production is regarded as the most comprehensive event that delivers industry best practices across the spectrum of upstream and downstream processing. Take advantage of early registration discounts by securing your seat today.

We invite you to join us on March 3-5 for this comprehensive 3Day program that will allow you to:

  • Evaluate the next generation technologies and processes that will further optimize cell culture
  • Hear approaches to integrate manufacturability assessments early to improve expression levels and quality
  • Examine the latest efforts to achieve process integration at the interface of upstream and downstream processing
  • Learn how continuous chromatography offers substantial economic advantages for affinity protein purification
  • Determine when an immunogenicity assessment is warranted
  • Gain a better understanding of the impact of QbD and DOE

By attending, you will learn how companies are developing the latest molecular assessment approaches to optimize manufacturability and product quality and how they are applying smarter and faster tools for rapid process development. Industry leaders will assess the state of the industry and offer solutions to overcome the current capacity issues as they work towards their goals of lean manufacturing and facility optimization.

Back by Popular Demand

Five Strategic Discussion Forums
Hear uncensored insights on the industry's most pressing challenges, including:

  • Enabling Technologies -What are the Tools that will Take Us to the Next Level?
  • Outsourcing of Upstream Bioprocess Development
  • Can the Biopharma Industry Make Better Progress Working Together as a Community Rather than Individual Companies? What are the Hurdles?
  • Using BioSMB™ or Other Multi Column Approaches to Enable Facility Fit for High Titer Processes and to Decrease Clinical Manufacturing Scale and Costs.
  • New Technologies for Antibody Purification
courses banner

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com

Powered by Interactive Agency Janmedia Interactive, Inc.